Navigation Links
Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials
Date:6/24/2009

    Release Highlights

    - Melogliptin continues to demonstrate potential to be the
      best-in-class in achieving glycemic control with low incidence of
      hypoglycemia and neutral effect on body weight

    - Global Phase III trials likely to start by end 2009

    - IND approved by USFDA

    - Glenmark takes a step closer towards becoming the first
      Indian company to have a truly global innovative drug for the world

In the recently completed 12 week Phase IIb clinical trial in 494 patients with type 2 diabetes mellitus (T2DM), 'Melogliptin', Glenmark's investigational medicine from a new class of diabetes treatments called dipeptidyl peptidase 4 (DPP-4) inhibitors, improved glycemic control in patients with type 2 diabetes mellitus and exhibited excellent safety and tolerability profile. In addition, patients taking Melogliptin experienced low incidence of hypoglycemia and neutral effect on body weight.

In this 12-week, randomized, double-blind, placebo-controlled, parallel group study, Melogliptin significantly reduced HbA1c from baseline as compared to placebo with a mean average reduction of 0.75% in patients receiving 50mg twice daily dose (p<0001) and 0.60 % in patients receiving 100 mg once daily dose (p<.0001).

In a subgroup of patients with higher baseline HbA1c of 8.5%-10%, Melogliptin reduced HbA1c from baseline as compared to placebo with a mean average reduction of 0.88 % and 1.05 % in patients receiving 100mg once daily dose and 50mg twice daily dose respectively, which compares favorably to reported results of other DPP-4's.

The Phase IIb results for Melogliptin demonstrate potential for offering class leading improvements in glycemic control and metabolic function. Glenmark recently received IND approval from the USFDA to carry out a clinical study in the US. Glenmark continues to be in discussions with various licensing partners
'/>"/>

SOURCE Glenmark Pharmaceuticals Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy
2. Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
3. Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus
4. Biomimetic-engineering design can replace spaghetti tangle of nanotubes in novel material
5. HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)
6. Novel method predicts impact of a covert anthrax release
7. ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imaging
8. ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imagin
9. New nanotube coating enables novel laser power meter
10. Nano-sandwich triggers novel electron behavior
11. ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... PALM BEACH, Fla. , July 11, 2014 /PRNewswire-iReach/ ... variety of high-quality peptides that are used solely in ... To honor two successful years in business, Maxim Peptide, ... LLC, has just launched a new and updated website ... the research blog section has been updated with fascinating ...
(Date:7/11/2014)... 11, 2014 , Not for release, ... or from any jurisdiction where to do so would constitute ... Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: ...  Shire confirms it has held a meeting with representatives of ... without the prior agreement or approval of AbbVie. ...
(Date:7/11/2014)... , July 11, 2014 Research and ... Transfection Technology Market - Global Industry Analysis, Size, Share, ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... nucleic acids (either DNA or RNA) into cells. This ... of cancer cells and protein metabolism by affecting the ...
(Date:7/11/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS , the global market ... $140 billion in 2013. This is estimated to grow ... annual growth rate (CAGR) of 28.6%. , New digital ... exciting possibilities within the broader PCR field. The opportunities ...
Breaking Biology Technology:Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2Shire plc - Statement re: Media Speculation 2International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3
... Oct. 20 Celsis International is pleased to announce ... issued U.S. Patent No. 7,604,929 to Celsis In Vitro ... by which the company creates its unique LiverPool(TM) products ... cells from multiple donors to create large lots with ...
... DENVER, Oct. 20 The Colorado Center for Reproductive Medicine ... for patients undergoing in vitro fertilization (IVF) with comprehensive chromosome ... pregnancy success rate is about 30% worldwide. , In ... for all 23 pairs of chromosomes in a few cells ...
... ROME, October 20 Speaking in Rome, ... International Osteoporosis Foundation,(IOF) CEO Patrice McKenney called for ... fight against osteoporosis. "Osteoporosis is a common but,devastating ... measures must,be taken to reduce the burden of ...
Cached Biology Technology:Celsis IVT Granted U.S. Patent for LiverPool(TM) Hepatocytes 2Colorado Center for Reproductive Medicine Improves Pregnancy and Implantation Rates Using Comprehensive Chromosomal Screening of IVF Embryos 2Colorado Center for Reproductive Medicine Improves Pregnancy and Implantation Rates Using Comprehensive Chromosomal Screening of IVF Embryos 3World Osteoporosis Day Call for Immediate Action to Prevent Fractures 2
(Date:7/11/2014)... Society shows that no-take zones in Belize can ... lobster, conch, and fish recover from overfishing, but ... The reporttitled "Review of the Benefits of No-Take ... no-take areas around the world. The report was ... in marine protected areas and fisheries management. The ...
(Date:7/11/2014)... OAK RIDGE, Tenn., July 11, 2014--Researchers at the ... received eight R&D 100 awards, presented by R&D ... innovations. , "These awards recognize the tremendous ... Energy Ernest Moniz. "Research and development at the ... its energy challenges and pursue the scientific and ...
(Date:7/11/2014)... in eastern New South Wales, Australia when NASA,s Aqua ... UTC on July 11 (12:35 p.m. local time/11:35 p.m. ... New South Wales (NSW), the Moderate Resolution Imaging Spectroradiometer ... region and spotted smoke (light brown) from various fires. ... outlined in red. , The New South Wales, Australia ...
Breaking Biology News(10 mins):Belize's lobster, conch, and fish populations rebuild in no-take zones 2ORNL wins eight R&D 100s 2ORNL wins eight R&D 100s 3ORNL wins eight R&D 100s 4
... In response to a complaint by People for ... has launched an inquiry into the actions of the ... the REACH chemical-testing program, which is expected to consume ... in July 2012, alleges that the European Chemicals Agency ...
... Colo., USA - Geology content posted online 4 through 25 ... observations of erupting geysers in Russia and from the age ... detailed information about each article are listed below. ... Earth ,3. Sagaing fault, Indo-Burmese wedge ,4. Anthropogenic lead ,5. ...
... Lakewood High School Team 1 won the Colorado High School ... National Science Bowl in Washington D.C., Apr. 25-29, where they ... students from 70 high schools. The U.S. Department of ... a way to encourage high school students to explore math ...
Cached Biology News:REACH news: European ombudsman takes up PETA complaint 2GEOLOGY starts 2013 with 25 new articles posted online ahead of print 2GEOLOGY starts 2013 with 25 new articles posted online ahead of print 3GEOLOGY starts 2013 with 25 new articles posted online ahead of print 4GEOLOGY starts 2013 with 25 new articles posted online ahead of print 5GEOLOGY starts 2013 with 25 new articles posted online ahead of print 6GEOLOGY starts 2013 with 25 new articles posted online ahead of print 7GEOLOGY starts 2013 with 25 new articles posted online ahead of print 8GEOLOGY starts 2013 with 25 new articles posted online ahead of print 9GEOLOGY starts 2013 with 25 new articles posted online ahead of print 10GEOLOGY starts 2013 with 25 new articles posted online ahead of print 11GEOLOGY starts 2013 with 25 new articles posted online ahead of print 12GEOLOGY starts 2013 with 25 new articles posted online ahead of print 13GEOLOGY starts 2013 with 25 new articles posted online ahead of print 14GEOLOGY starts 2013 with 25 new articles posted online ahead of print 15GEOLOGY starts 2013 with 25 new articles posted online ahead of print 16GEOLOGY starts 2013 with 25 new articles posted online ahead of print 17GEOLOGY starts 2013 with 25 new articles posted online ahead of print 18GEOLOGY starts 2013 with 25 new articles posted online ahead of print 19GEOLOGY starts 2013 with 25 new articles posted online ahead of print 20GEOLOGY starts 2013 with 25 new articles posted online ahead of print 21